Evolution of thyroid cancer mortality in adults in Brazil;Evolução da mortalidade por câncer de tireoide em adultos no Brasil

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 57, Issue 7, 2013, Pages 538-544

  Guimarães, Raphael Mendonça ^a   Muzi, Camila Drumond ^b   Parreira, Viviane Gomes ^c   dos Santos, Renan Duarte ^a   Cavalcante Sampaio, João Roberto ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^c Secretaria Municipal de Saude e Defesa Civil do Rio de Janeiro   (Brazil)

Author keywords

Epidemiology; Historical series; Mortality; Thyroid cancer

Indexed keywords

ADULT; AGED; ARTICLE; BRAZIL; FEMALE; HUMAN; MALE; MIDDLE AGED; MORTALITY; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; THYROID TUMOR; YOUNG ADULT;

ADULT; AGED; BRAZIL; FEMALE; HUMANS; MALE; MIDDLE AGED; MORTALITY; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; THYROID NEOPLASMS; YOUNG ADULT;

EID: 84887681305     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/S0004-27302013000700007     Document Type: Article

References (40)

1. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA. 2006;295(18):2164-7.
2. American Cancer Society. Cancer Facts and Figures 2012. Atlanta, USA: American Cancer Society; 2012. 68p. Avaiable from: http://www.cancer.org/acs/ groups/content/@epidemiologysurveilance/ documents/document/acspc-031941.pdf. Accessed on: Oct, 12, 2012.
3. Rossi RL, Majlis D, Rossi RM. Thyroid cancer. Surg Clin North Am. 2000;80:571-80.
4. DeGroot LJ, Kaplan EL, McCormick M, Straus FH. Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab. 1990;71:414-24.
5. Ward LS, Assumpção LVM. Thyroid cancer: prognostic factors and treatment. Arq Bras Endocrinol Metab. 2004;48(1):126-36.
6. Dillon LW, Lehman CE, Wang YH. The role of fragile sites in sporadic papillary thyroid carcinoma. J Thyroid Res. 2012;2012:1-12.
7. Brasil. Ministério da Saúde. Secretaria de Assistência à Saúde. Instituto Nacional de Câncer José Alencar Gomes da Silva. Estimativas da incidência e mortalidade por câncer. Rio de Janeiro: INCA, 2012. Avaiable from: http://www.inca.gov.br/ estimativa/2012/tabelaestados.asp?UF=BR. Accessed on: Oct 5, 2012.
8. WHO. IARC. GLOBOCAN 2008: Cancer Incidence, Mortality and Prevalence Worldwide. Avaiable from: http://globocan.iarc.fr/ factsheets/populations/ factsheet.asp?uno=9007. Avaiable from: Oct 6, 2012.
9. Hegedus L. Clinical practice. The thyroid nodule. N Engl J Med. 2004;351(17):1764-71.
10. Romagnoli S, Moretti S, Voce P, Puxeddu E. Terapias moleculares direcionadas em câncer de tireoide. Arq Bras Endocrinol Metab. 2009;53(9): 1061-73.
11. Cordioli MIVC, Canalli MHBS, Coral MHC. Increase incidence of thyroid cancer in Florianopolis, Brazil: comparative study of diagnosed cases in 2000 and 2005. Arq Bras Endocrinol Metab. 2009;53(4):453-60.
12. Sprague BL, Warren Andersen S, Trentham-Dietz A. Thyroid cancer incidence and socioeconomic indicators of health care access. Cancer Causes Control. 2008;19(6):585-93.
13. Zhang Y, Zhu Y, Risch HA. Changing incidence of thyroid cancer. J American Medical Association. 2006;296(11):1350.
14. How J, Tabah R. Explaining the increasing incidence of differentiated thyroid cancer. CMAJ. 2007;177(11):1383-4.
15. Cardis E, Howe G, Ron E, Bebeshko V, Bogdanova T, Bouville A, et al. Cancer consequences of the Chernobyl accident: 20 years on. J Radiol Prot. 2006;26:127-40.
16. Kitahara CM, Platz EA, Freeman LE, Hsing AW, Linet MS, Park Y, et al. Obesity and thyroid cancer risk among U.S. men and women: a pooled analysis of five prospective studies. Cancer Epidemiology Biomarkers Prev. 2011;20(3):464-72.
17. Lind P, Kumnig G, Heinisch M, Igerc I, Mikosch P, Gallowitsch HJ, et al. Iodine supplementation in Austria: methods and results. Thyroid. 2002;12(10):903-7.
18. Burgess JR, Tucker P. Incidence trends for papillary thyroid carcinoma and their correlation with thyroid surgery and thyroid fineneedle aspirate cytology. Thyroid. 2006;16(1):47-53.
19. Haselkorn T, Bernstein L, Preston-Martin S, Cozen W, Mack WJ. Descriptive epidemiology of thyroid cancer in Los Angeles County, 1972-1995. Cancer Causes Control. 2000;11(2):163-70.
20. Segi M, Fujisaku S, Kurihara M, Narai Y, Sasajima K. The ageadjusted death rates for malignant neoplasms in some selected sites in 23 countries in 1954-1955 and their geographical correlation. Tohoku J Exp Med. 1960;72:91-103.
21. Doll R, Waterhouse J, Payne P. Cancer incidence in five continents: a technical report. Berlin: International Agency for Research on Cancer; 1966.
22. Greene WH. Econometric Analysis. 6th ed. New Jersey: Pearson Prentice Hall; 2008.
23. Latorre MRDO, Cardoso MRA. Análise de séries temporais em epidemiologia: uma introdução sobre os aspectos metodológicos. Rev Bras Epidemiol. 2001;4(3):145-52.
24. Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19:335-51.
25. Sprague BL, Warren Andersen S, Trentham-Dietz A. Thyroid cancer incidence and socioeconomic indicators of health care access. Cancer Causes Control. 2008;19(6):585-93.
26. Ronckers C, Ron E. Thyroid cancer. Cancer incidence in four member countries (Cyprus, Egypt, Israel, and Jordan) of the Middle East cancer consortium (MECC) compared with US SEER. National Cancer Institute; 2006. Avaiable from: http://mecc. cancer.gov/publication/mecc-monograph.pdf. Accessed on: Oct 1, 2012.
27. Ward LS, Morari EC, Leite JL, Bufalo NE, Guilhen AC, de Araujo PP, et al. Identifying a risk profile for thyroid cancer. Arq Bras Endocrinol Metabol. 2007;51:713-22.
28. Coeli CM, Brito AS, Barbosa FS, Ribeiro MG, Sieiro AP, Vaisman M. Incidence and mortality from thyroid cancer in Brazil. Arq Bras Endocrinol Metabol. 2005;49:503-9.
29. Mitchell I, Livingston EH, Chang AY, Holt S, Snyder WH 3rd, Lingvay I, et al. Trends in thyroid cancer demographics and surgical therapy in the United States. Surgery. 2007;142(6):823-8.
30. Lope V, Pollán M, Pérez-Gómez B, Aragonés N, Ramis R, Gómez-Barroso D, et al. Municipal mortality due to thyroid cancer in Spain. BMC Public Health. 2006;6:302.
31. Netea-Maier RT, Aben KK, Casparie MK, den Heijer M, Grefte JM, Slootweg P, et al. Trends in incidence and mortality of thyroid carcinoma in The Netherlands between 1989 and 2003: correlation with thyroid fine-needle aspiration cytology and thyroid surgery. Int J Cancer. 2008;123(7):1681-4.
32. Lin JD, Chao TC, Sun JH, Ho C, Weng HF. Trends in the clinical characteristics of patients with papillary thyroid carcinoma in Taiwan. Oncology. 2000;58(4):280-5.
33. Crocetti E, Capocaccia R, Casella C, Guzzinati S, Ferretti S, Rosso S, et al.; Network of the Italian Cancer Registries (AIRT). Population-based incidence and mortality cancer trends (1986-1997) from the network of Italian cancer registries. Eur J Cancer Prev. 2004;13(4):287-95.
34. Reynolds RM, Weir J, Stockton DL, Brewster DH, Sandeep TC, Strachan MW. Changing trends in incidence and mortality of thyroid cancer in Scotland. Clin Endocrinol (Oxf). 2005;62(2):156-62.
35. Davies L, Welch HG. Epidemiology of head and neck cancer in the United States. Otolaryngol Head Neck Surg. 2006;135(3):451-7.
36. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA. 2006;295(18):2164-7.
37. Scheiden R, Keipes M, Bock C, Dippel W, Kieffer N, Capesius C. Thyroid cancer in Luxembourg: a national population-based data report (1983-1999). BMC Cancer. 2006;6:102.
38. Ramírez-Vick M, Nieves-Rodríguez M, Lúgaro-Gómez A, Pérez-Irizarry J. Increasing incidence of thyroid cancer in Puerto Rico, 1985-2004. P R Health Sci J. 2011;30(3):109-15.
39. Bukvic B, Sipetic S, Kalezic N, Diklic A, Paunovic I, Kovacevic B, et al. Changing trends in mortality of thyroid cancer in Belgrade population. J BUON. 2011;16(2):337-40.
40. Colonna M, Bossard N, Guizard AV, Remontet L, Grosclaude P; le Réseau Francim. Descriptive epidemiology of thyroid cancer in France: incidence, mortality and survival. Ann Endocrinol (Paris). 2010;71(2):95-10.